JPMorgan Chase & Co’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$26 | – | 6350 |
|
|
2025
Q1 | $26 | Hold |
1
| – | – | ﹤0.01% | 6206 |
|
|
2024
Q4 | $34 | Hold |
1
| – | – | ﹤0.01% | 6140 |
|
|
2024
Q3 | $24 | Sell |
1
-1
| -50% | -$24 | ﹤0.01% | 6160 |
|
|
2024
Q2 | $43 | Sell |
2
-844
| -100% | -$18.1K | ﹤0.01% | 6024 |
|
|
2024
Q1 | $254K | Buy |
846
+830
| +5,188% | +$249K | ﹤0.01% | 4338 |
|
|
2023
Q4 | $3.81K | Buy |
16
+11
| +220% | +$2.62K | ﹤0.01% | 5576 |
|
|
2023
Q3 | $699 | Sell |
5
-3
| -38% | -$419 | ﹤0.01% | 5726 |
|
|
2023
Q2 | $1.37K | Sell |
8
-54
| -87% | -$9.27K | ﹤0.01% | 5502 |
|
|
2023
Q1 | $8K | Buy |
+62
| New | +$8K | ﹤0.01% | 5314 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5715 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5632 |
|
|
2022
Q2 | – | Sell |
-15
| Closed | -$2K | – | 5713 |
|
|
2022
Q1 | $2K | Buy |
15
+3
| +25% | +$400 | ﹤0.01% | 5588 |
|
|
2021
Q4 | $2K | Sell |
12
-294
| -96% | -$49K | ﹤0.01% | 5589 |
|
|
2021
Q3 | $67K | Sell |
306
-2,333
| -88% | -$511K | ﹤0.01% | 4868 |
|
|
2021
Q2 | $612K | Buy |
2,639
+117
| +5% | +$27.1K | ﹤0.01% | 3883 |
|
|
2021
Q1 | $759K | Buy |
2,522
+494
| +24% | +$149K | ﹤0.01% | 3814 |
|
|
2020
Q4 | $763K | Buy |
2,028
+1,282
| +172% | +$482K | ﹤0.01% | 3516 |
|
|
2020
Q3 | $233K | Sell |
746
-192
| -20% | -$60K | ﹤0.01% | 3666 |
|
|
2020
Q2 | $353K | Buy |
938
+627
| +202% | +$236K | ﹤0.01% | 3437 |
|
|
2020
Q1 | $71K | Buy |
311
+200
| +180% | +$45.7K | ﹤0.01% | 4039 |
|
|
2019
Q4 | $59K | Hold |
111
| – | – | ﹤0.01% | 4182 |
|
|
2019
Q3 | $48K | Buy |
111
+18
| +19% | +$7.78K | ﹤0.01% | 4272 |
|
|
2019
Q2 | $107K | Buy |
93
+10
| +12% | +$11.5K | ﹤0.01% | 3998 |
|
|
2019
Q1 | $104K | Sell |
83
-233
| -74% | -$292K | ﹤0.01% | 3994 |
|
|
2018
Q4 | $298K | Buy |
316
+237
| +300% | +$224K | ﹤0.01% | 3624 |
|
|
2018
Q3 | $114K | Buy |
79
+11
| +16% | +$15.9K | ﹤0.01% | 4067 |
|
|
2018
Q2 | $110K | Buy |
+68
| New | +$110K | ﹤0.01% | 4053 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4729 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4684 |
|
|
2017
Q2 | – | Sell |
-77
| Closed | -$42K | – | 4392 |
|
|
2017
Q1 | $42K | Buy |
77
+46
| +148% | +$25.1K | ﹤0.01% | 3967 |
|
|
2016
Q4 | $19K | Buy |
+31
| New | +$19K | ﹤0.01% | 4171 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4196 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4090 |
|
|
2015
Q2 | – | Sell |
-755
| Closed | -$628K | – | 3442 |
|
|
2015
Q1 | $628K | Sell |
755
-251
| -25% | -$209K | ﹤0.01% | 3016 |
|
|
2014
Q4 | $724K | Buy |
+1,006
| New | +$724K | ﹤0.01% | 2909 |
|